Agree, even thought ADAPT has been clinically proven to provide the most durable valve technology on the market there wasn't a point of difference with the other product which had less durability, TAVR now being prefer method of heart surgery for younger patient is the game changer so valve durability is a very important point of difference when comparing other product on the market.
"Toot Toot", page-68
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.95 |
Change
0.200(1.01%) |
Mkt cap ! $379.6M | |||
| Open | High | Low | Value | Volume |
| $19.95 | $19.95 | $19.95 | $14.84K | 744 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1 | $19.95 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.99 | 721 | 1 |
View Market Depth
| Last trade - 09.59am 14/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |